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RESUMEN 
El síndrome de estrés medial de la tibia (SEMT) constituye una de las afecciones más 
comunes del miembro inferior. Los resultados obtenidos con terapias convencionales en esta 
patología son dispares. La infiltración local de corticoides ha mostrado producir efectos 
favorables en el tratamiento de diversos problemas musculoesqueléticos. El efecto de la 
infiltración local multipuntual de un corticoide en combinación con un anestésico se estudió en 
47 pacientes (29 hombres y 18 mujeres, con una edad media de 23.8) afectos de SEMT. La 
consulta directa y el examen físico se emplearon para valorar los resultados. Los pacientes 
fueron valorados una vez a la semana tras la primera aplicación durante las primeras cuatro 
semanas y 3 meses después del tratamiento. El nivel de actividad en ausencia de síntomas fue 
registrado en cada caso. Los resultados de la infiltración multipuntual se determinaron 
comparando los niveles de actividad en ausencia de síntomas preintervención y 
posintervención y la capacidad de los deportistas para volver a los niveles de actividad 
presintomáticos. Los resultados sugieren que este tratamiento reduce el tiempo de 
recuperación y mejora los resultados funcionales 
 
ABSTRACT 
Medial stress tibial syndrome (MTSS) has been and remains one of the most common 
pathologic conditions of the lower extremity. The results of conventional therapies for this 
condition have been inconsistent. Local corticosteroid injection has been shown to have 
favourable effects in treating musculoskeletal disorders. The effect of local multipunctual 
injections of a corticosteroid combined with an anaesthetic was studied in 47 patients (29 male 
and 18 female subjects, with an average age of 23.8 years) with MTSS. Direct consultation and 
examination was used to assess outcome. Patients were evaluated once a week after first 
injection for the first 4 weeks, and 3 months after treatment as well. Level of symptoms-free 
activity was recorded for each patient. The outcomes of the multipunctual injections were 
determined by comparing preintervention and posintervention level of symptoms-free activity 
and ability of the athletes to return to presymptom levels of exercise. The results suggest that 
the treatment reduces the recovery time and improves functional outcomes. 
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Tibial stress injuries represent a significant 
cause of exercise-induced leg pain. Medialtibial 
stress syndrome (MTSS) is a common complaint 
among runners that can become a debilitating 
injury. Affecting predominantly female athletes(1, 
2), it accounts for between 13.2% and 17.3% of 
all running injuries(3). It has been considered as 
the fifth most common injury and, when 
combined with tibial stress fracture, would be the 
third most common injury behind only 
patellofemoral pain syndrome and iliotibial band 
friction syndrome(4). Certain studies report up to 
a 35% incidence of MTSS in actively training 
military recruits and 13% in civilian runners(5). 
Bennett looked at high school cross-country 
runners over the course of a season and found 
12% developed MTSS (19% in females)(6). 
 
MTSS represents a multifactorial etiologic 
disorder in which the most evident 
characteristic is recurrent pain over the frontal 
or posteromedial aspect of the middle and 
lower third of the tibia (7-10). It is a condition 
which begins with an insidious onset. It may be 
seen unilaterally, although more frequently 
both legs are affected, with one leg being more 
severe than the other. It is an extremely 
common complaint among runners that 
becomes progressively worse with repetitive 
impact activities, frequently leading to athletes 
having to curtail their activity(11-14). MTSS is 
clearly located along the shin with little or no 
radiation. The current thinking regards it as a 
chronic periosteal irritation due to fascial 
traction, usually secondary to prolonged 
exercise (ie. an overuse injury, especially when 
eccentric work is performed)(9, 15-17), since 
inflammatory changes have been found in the 
insertion of the periosteum, fascia or muscle, 
or both(18-20). 
 
Currently, little evidence exists in the literature 
to support the use of the most commonly 
applied interventions for the treatment of 
MTSS(13). Traditional treatments include local 
cryotherapy, stretching and strengthening of 
gastrocnemius-soleus musculature, the use of 
nonsteroidal anti-inflammatory drugs 
(NSAIDs), iontophoresis with calcium or 
corticosteroids, modification of training 
regimens, orthotic devices to correct for 
biomechanical abnormalities, and rest(10, 21-
26). 
Local corticosteroid injection has been shown 
to have favourable effects in alleviating pain, 
swelling and dysfunction in musculoskeletal 
disorders(27-31), even when compared to 
more conservative treatments in a short term 
follow up assessment(32). Soft-tissue injuries 
such as tendinopathies or sprains have been 
effectively treated with this modality. As an 
inflammatory condition affecting soft tissues, 
MTSS can potentially be treated by local 
cortisone administration. To the authors´ 
knowledge, the application of multipunctual 
corticosteroid injections on MTSS has not been 
previously reported. 
 
We hypothesize that local multipunctual 
corticosteroid injections applied to the 
posteromedial aspect of the middle and lower 
third of the tibia, at the soleus insertion, could 
be helpful when treating MTSS. 
 
MATERIAL AND METHODS 
 
In this case series study, over a 14-month-
period between 2001 and 2003, a convenience 
sample of 47 patients with MTSS referred to 
the clinic were examined and treated by two of 
us (AJ and IM). This sample was 100% of the 
subjects referred with MTSS during this time 
period, each of whom signed an informed 
consent form reiterating the basic procedures 
and intent of the study and warning of any 
potential risks as a result of participation. All of 
them completed a baseline history form that 
addressed the patients´ age, gender and level 
of sports participation. 
 
Physical examination. MTSS was defined as 
recurrent pain over the frontal or posteromedial 
aspect of the middle and lower third of the tibia, 
exacerbated with specific, local palpation and 
weight-bearing repetitive activities(7, 8, 33, 34). 
The presence of clinical evidence of 
compartment syndrome or muscle herniation, or 
a positive percussion test on the tibia were 
considered causes of exclusion. Patients were 
examined by a licensed physical therapist with 
10 to 22 years of clinical experience to 
determine if he or she met the criteria for MTSS. 
The location of pain and tenderness and the 
duration of symptoms were also recorded.  
 
Tibial soft tissue traction test (Figure 1) and 
tender area palpation were performed and 
recorded in each case. Early in this series, all 
patients were conservatively treated during the 
first nine sessions -2 weeks- (Table 1). After 9th 
session the first injections were given. 
Corticosteroid injections were considered and 
discussed only after noninvasive treatment was 
deemed to have failed by both the therapists and 
the patient. In this series, no patient received the 
injection before a minimum of 9 sessions of 
treatment (range, 9 to 11). 
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Figure 1. Soft-tissue traction test. 
 
 
Table 1. Conservative Treatment Protocol for 
MTSS. 
Relative rest 
Stretching of gasctrocnemius-soleus 
musculature 
Local cryotherapy (ice massage for 10-12 
minutes, three times a day) 
Ultrasound (commonly 1 Mhz frequency, 0.8-1.2 
W/cm2 intensity, applied for 6-8 minutes 
depending on the injured area) 
Periosteal massage 
Eccentric work of gasctrocnemius-soleus and 
tibialis posterior  
 
 
Corticosteroid injection technique. Before 
injection, the area was scrubbed with povidone 
iodine. A careful palpation of the tender area and 
a positive soft tissue pain provocation test were 
necessary in order to determine correct needle 
placement (Figure 2), in the soleus fascial origin.  
 
The administered dose of the injection was 3 cc, 
in equal shares betamethasone (celestone 
cronodose®) and local anaesthetic 
(scandinibsa®). Six or seven low penetration 
injections of 0.4-0.5 ml. each were performed, 
no more than 4-5 mm deep using thin board 
needles (0.4 x 25mm). If a second or third set of 
injections was necessary they were given one 
and two weeks after the first injection. 
 
Postinjection regimen. Two days after the first 
set of injections, sport activity was progressively 
introduced with the following progression criteria 
during the first week: general and specific 
stretching of the injured area; running on a soft  
 
 
Figure 2. Needle placements when applying 
multipunctual corticosteroid injections. 
 
surface (for example, grass, sand) for ten 
minutes; progressive series of runs (5 x 60m) at  
80% of maximum pain free intensity; and local 
cryotherapy (ice massage for 10-12 minutes, 
three times a day). The main criterion for 
returning to sport activities was that the subject 
be able to perform specific individual activities 
(e.g. running, high jump, long jump) without pain, 
or with minimal discomfort (VAS score < 2). 
 
Follow-up evaluation. Direct consultation and 
examination was used to assess outcome. 
Posinjection symptoms performing their previous 
activity were recorded for each patient. We 
evaluated the patient once a week after first 
injection for the first 4 weeks, and 3 months after 
treatment as well in order to assess their level of 
activity. The outcomes of this injection technique 
were determined by comparing preintervention 
and posintervention ability of the athletes to 




There were 29 male and 18 female subjects, 
with an average age of 23.8 years (range, 19 to 
38 years). The location of pain was as follows: 
posteromedial distal third, in 42 athletes 
(89.4%); posteromedial middle-upper third, in 4 
athletes (8.5%); and posteromedial upper third in 
just one athlete (2.1%). 
 
In 41 subjects (87.2%), the pain was bilateral. 
Six of these patients (12.8%) had unilateral pain. 
All of the patients in the series were involved in 
sports although the majority of patients felt their 
problem was work related –recreational: 4; 
amateur: 3; professional: 4; workrelated: 36. 
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Thirty-eight of the patients (80.8%) were 
runners. In all cases, pain was work-related. 
All of the patients included in this study were 
given at least one series of injections. Thirty-one 
patients (65.9%) received two sets of injections. 
Twelve (25.5%) required a third infiltration to 
alleviate their symptoms. Those patients 
demonstrating a larger site of symptoms 
received more injections but the same amount of 
medication. Thirty-nine (82.9%) of 47 treated 
athletes returned to complete activity with no 
pain associated with sport activity after four 
weeks, whereas six of them (12.8%) referred 
minimal discomfort. Two subjects (4.3%) 
returned to sport activity 6 weeks from the 
beginning of the treatment with minimal 
discomfort. Four athletes suffered a relapse after 
three months of training. There were neither 
device-related problems nor systemic or local 




As both etiology and pathophysiological 
mechanism of this syndrome are still not well 
understood, there is no consensus about its 
management. The recommended physical 
therapy treatment for MTSS includes rest from 
specific physical activity(7, 16, 21, 24), 
ultrasound(16, 23), phonophoresis(23), 
iontophoresis with calcium or corticosteroids(23, 
25), use of oral antiinflamatory medication(7, 21, 
24), stretching of gastrocnemius-soleus 
musculature(23, 33), local cryotherapy(23, 24, 
34), orthotic devices(12) or even plaster cast 
immobilization, and a gradual return to full 
activity(7). There is a paucity of evidence 
supporting the use of many of these 
interventions and none of these treatments by 
themselves or in combination have been 
definitively demonstrated to be efficacious(11, 
22). In certain cases the results of treatment 
have been very discouraging(35). As an 
inflammatory condition affecting soft tissues, we 
hypothesized that MTSS can potentially be 
treated by local cortisone administration with 
similar results than other musculoskeletal 
disorders(27-32). Adverse effects such as 
postinjection pain or skin atrophy over the 
injection site, as well as systemic effects –
vasovagal syncope, hiccoughs, excitement or 
medication allergy– have been reported(42). The 
small amount of medication administered(29) in 
each injection, as well as the combined use of 
anaesthetic, may be an explanation for the 
absence of local side-effects when using this 
multipunctual technique. Five patients (10.6%) 
reported slight discomfort and/or tenderness in 
the injected region, likely due to the impact of 
multiple needles. 
 
The MTSS term was first introduced by 
Puranen(19) in 1974, who suggested the pain 
resulted from ischemia of the deep flexor 
compartment muscles, secondary to an increase 
in the intracompartimental pressure caused by 
prolonged exercise and fascial thickening and 
shortening. This finding was supported by the 
immediate relief provided by fasciotomy.  
 
However, Puranen´s conclusions were later 
questioned since no relationship between this 
syndrome and the increase of 
intracompartimental pressure was 
demonstrated(18, 36). In 1978, James et al. 
suggested that the problem –presence of pain– 
was due to injury to the tibialis posterior 
attachment in this area(12), although 
subsequent studies(33, 37) have demonstrated 
a more lateral tibial origin for tibialis posterior. In 
1982, Mubarak et al. proposed periostitis as the 
cornerstone of the condition(36), although 
analysis has shown that periosteal swelling and 
pain do not always coexist(17). Three years 
later, Michael and Holder identified the soleus 
muscle and its investing fascia as the main 
structures anatomically and biomechanically 
implicated in the production of this condition, 
which they named as soleus syndrome(33).  
 
Finally, in 1994, Beck and Osternig provided 
confirmatory evidence that soleus and flexor 
digitorum longus were more consistently 
attached on the symptomatic area, and that the 
posterior tibial fibers did not insert into the lower 
third of the lateral tibia and interosseus 
membrane(37). According to these authors, from 
an anatomic point of view, treatment modalities 
should focus on the posteromedial aspect of the 
middle and lower third of the tibia, that´s to say, 
the soleus insertion. 
 
The diagnosis of MTSS is primarily a clinical 
one. In our experience, every patient with MTSS 
has a diffuse region of tenderness along the 
posteromedial edge of the tibia. This tenderness 
is generally present in the middle and distal 
thirds of the tibia, from approximately 12 cm 
proximal to the medial malleollus, extending 
distally to about 4 cm proximal(11). Several 
authors have reported that the most common 
location of pain was the lower third of the 
posteromedial border of the tibia(8, 33, 38), 
although this site may vary depending on sport 
activity, since different structures may be 
recruited and stressed(33, 36). Again, clinical 
findings support what anatomy suggested 
initially: any local corticoid administration should 
be proportionally applied along the site of pain. 
Beck and Osternig(37), as well as James(39), 
have highlighted the soleus fascia as the main 
structure that inserts into the whole medial tibial 
border and is likely to be responsible for the 
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pain, discarding prior studies that sustained that 
the tibialis posterior may contribute to this 
condition(38). One test which the authors found 
to be useful is one which consists of tissue 
traction applied by the heel of the examiner´s 
hand along the posteromedial border of the tibia, 
stretching the soleus fascia. A sharp pain elicited 
in the location that patients have reported as the 
most painful area indicates a positive finding. In 
all 47 patients, this test was positive. 
 
Classically, the surgical intervention most often 
proposed is subcutaneous fasciotomy together 
with periosteal cauterisation or soleus 
disattachment from the tibial medial border(18, 
40, 41). These techniques are supposed to 
release the pressure within the compartment. 
Since no relationship has been demonstrated 
between this syndrome and the increase of 
intracompartimental pressure(36), surgery has 
rarely been considered as the first option for 
treatment. Wallenstein, for example, found a 
complete relief of symptoms in only 5 of the 9 
MTSS patients who underwent fasciotomy(18). 
Nonetheless, when conservative modalities fail, 
surgery is indicated(33). 
 
These results suggest that a more rapid return to 
activity and a functional improvement can be 
achieved through the judicious use of 
multipunctual corticosteroid injections. The most 
appropiate corticosteroid, dose, injection volume 
and injection interval remains unclear(31). The 
authors assume that corticosteroid injection 
represents a symptomatic short term treatment 
that is potentially revocable(31), but may be 
beneficial in athletes who need to return to 
competition within 2 weeks, as advocated by 
Fricker et al(43). Thus, some other conservative 
measures such as running technique 
modification, terrain changes, muscle stretching, 
foot control or orthotic support must be added as 
needed in order to avoid any relapse(7, 14, 23, 
33). Future research to test our hypotheses 
should include randomized, controlled trials that 
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